Suppr超能文献

接受高容量血液滤过和持续静静脉血液滤过的脓毒症患者血清白细胞介素-6和白细胞介素-1受体拮抗剂与序贯器官衰竭评估评分的关系

Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration.

作者信息

Ghani Rohana Abdul, Zainudin Soehardy, Ctkong Norella, Rahman Ahmad Fauzi Abdul, Wafa Syed Rozaidi Wafa Syed Hussain, Mohamad Marlyn, Manaf Mohd Rizal Abdul, Ismail Rahimah

机构信息

Department of Medicine, Hospital Universiti Kebangsaan Malaysia, Jalan Yaacob Latiff, Kuala Lumpar, Malaysia.

出版信息

Nephrology (Carlton). 2006 Oct;11(5):386-93. doi: 10.1111/j.1440-1797.2006.00600.x.

Abstract

AIM

Sepsis is characterized by an uncontrolled release of pro-inflammatory and anti-inflammatory mediators leading to immunoparalysis, cellular and humoral dysfunction, multiorgan dysfunction and death. This study evaluated the efficacy of high-volume haemofiltration (HVHF) compared with continuous venovenous haemofiltration (CVVH) in removing these inflammatory mediators. Clinical responses were assessed with the sequential organ failure assessment (SOFA) score.

METHODS

Septic patients with an end-organ dysfunction or septic shock were randomized to receive 6 h of CVVH (ultrafiltration dose of 2 L/h equivalent to about 35 mL/kg per hour or HVHF (ultrafiltration dose of 100 mL/kg per hour or 6 L/h, whichever was higher). The sequential organ failures were scored for the 24 hours preceding recruitment; at day 1, day 7, at discharge from the intensive care unit and at hospital discharge.

RESULTS

Thirty-three patients were enrolled. Fifteen received HVHF and 18 received CVVH. The serum IL-6 levels (pg/mL) at baseline were similarly elevated in both groups (P = 0.745). The HVHF group showed a significant reduction after 6 h of treatment with a median interquartile range (IQR) of 20.62 (49.21) pg/mL (P = 0.025) with no similar result in the CVVH group. Non-survivors showed a higher baseline serum IL-6 compared with the survivors (median (IQR) 172.31 (261.34) vs 58.9 (104.21), P = 0.044). In the HVHF group there was a positive association between the IL-6 levels at 6 h with the SOFA scores at day 1 (r = 0.392, P = 0.001) but not at day 7. After 6 h of treatment in the HVHF group there was a direct correlation between the IL-6 levels and number of hospital days (r = 0.90, P = 0.040). The maximum SOFA scores were persistently recorded before treatment. The SOFA scores reduced in both groups from baseline to day 7 (HVHF P = 0.048; CVVH P = 0.006). The SOFA scores at day 1 is significantly higher in the non-survivors compared with the survivors (P = 0.038).

CONCLUSIONS

High-volume haemofiltration at 6 L/h may seem to successfully remove some inflammatory cytokines in septic patients. The improvement in the SOFA scores at day 7 promises benefit of continuous renal replacement therapy in septic patients, but after 20 days this effect may be lost. In addition, the baseline serum IL-6 and IL-1-ra were independent predictors of a poor outcome as reflected by the higher SOFA scores at day 1.

摘要

目的

脓毒症的特征是促炎和抗炎介质的失控释放,导致免疫麻痹、细胞和体液功能障碍、多器官功能障碍及死亡。本研究评估了高容量血液滤过(HVHF)与连续性静脉-静脉血液滤过(CVVH)在清除这些炎症介质方面的疗效。采用序贯器官衰竭评估(SOFA)评分评估临床反应。

方法

将伴有终末器官功能障碍或脓毒性休克的脓毒症患者随机分组,分别接受6小时的CVVH(超滤剂量为2L/h,相当于约35mL/kg每小时)或HVHF(超滤剂量为100mL/kg每小时或6L/h,以较高者为准)。在入组前24小时、第1天、第7天、重症监护病房出院时及医院出院时对序贯器官衰竭进行评分。

结果

共纳入33例患者。15例接受HVHF,18例接受CVVH。两组基线时血清IL-6水平(pg/mL)同样升高(P = 0.745)。HVHF组治疗6小时后显著降低,中位数四分位数间距(IQR)为20.62(49.21)pg/mL(P = 0.025),CVVH组无类似结果。非幸存者的基线血清IL-6高于幸存者(中位数(IQR)172.31(261.34)对58.9(104.21),P = 0.044)。在HVHF组,6小时时的IL-6水平与第1天的SOFA评分呈正相关(r = 0.392,P = 0.001),但与第7天无关。HVHF组治疗6小时后,IL-6水平与住院天数呈直接相关(r = 0.90,P = 0.040)。治疗前持续记录最高SOFA评分。两组的SOFA评分从基线到第7天均降低(HVHF组P = 0.048;CVVH组P = 0.006)。非幸存者第1天的SOFA评分显著高于幸存者(P = 0.038)。

结论

6L/h的高容量血液滤过似乎能成功清除脓毒症患者的一些炎症细胞因子。第7天SOFA评分的改善表明连续性肾脏替代疗法对脓毒症患者有益,但20天后这种效果可能消失。此外,基线血清IL-6和IL-1-ra是第1天较高SOFA评分所反映的不良预后的独立预测因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验